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OBJECTIVES We sought to determine the association of age with the change in quality of life (QOL) after
valve surgery.
BACKGROUND Improvement in QOL is one of the principal goals of valve surgery. These procedures are
being done with increasing frequency for older patients.
METHODS We prospectively studied 148 patients with aortic valve procedures and 72 patients with
mitral valve procedures. Patients’ QOL was measured at baseline and at 18 months using the
Medical Outcomes Trust Short Form 36-Item (SF-36) Health Survey (response rate 90%).
The association of age with change in QOL was measured by multiple regression analysis and
based on two meta-scores of the SF-36: the Mental Component Summary (MCS) and the
Physical Component Summary (PCS).
RESULTS Overall improvement in most domains of the SF-36, including the MCS and the PCS scores,
was substantial. Improvement in the MCS score was not influenced by age in either aortic
(0.09 score point improvement per 10-year age increments; p  0.9) or mitral (0.90 score
point improvement per 10-year age increments; p  0.3) patients. Similarly, improvement in
the PCS score did not vary by age in aortic patients (1.00 score points per 10-year age
increments; p 0.2) and only slightly varied by age in mitral patients (1.90 score points per
10-year age increments, p 0.02). In the latter, despite statistical significance, the association
was not substantial or clinically important.
CONCLUSIONS Among patients referred for cardiac valve surgery, age does not appear to limit the QOL
benefits of surgery. (J Am Coll Cardiol 2003;42:1208–14) © 2003 by the American College
of Cardiology Foundation
More than 79,000 cardiac valve replacement procedures are
performed annually in the U.S. (1,2), with more than 16%
performed for patients who are older than 75 years of age
(3,4). Given the rapidly growing older population (5) and
the increasing prevalence of symptomatic valve disease with
advancing age (6,7), the number of elderly patients referred
for cardiac valve surgery is likely to grow.
See page 1215
Several recent studies have reported “acceptable” opera-
tive risk (in-hospital mortality 11% to 14%) and late survival
(five-year survival 70%) for elderly patients undergoing
cardiac surgery (8–10). However, because the long-term
consequences of cardiac valve surgery extend beyond mere
survival and morbidity, physicians are often hesitant to
recommend surgery based on mortality data alone (11). In
addition, cardiac valve surgery in elderly patients is still
associated with higher resource utilization and morbidity
than in younger patients (9,10,12).
There is a growing interest in the use of health status to
evaluate clinical strategies. Improvement in quality of life
(QOL) is considered to be one of the principal goals of valve
surgery (13). Patients deciding among treatment options
may value information about the change in QOL that they
can expect after valve surgery. It is particularly important to
evaluate QOL in elderly patients, who have a higher
prevalence of comorbidity, stress of surgery, and rate of
complications—all factors that may hinder improvement in
QOL. Moreover, whether age modifies the expected QOL
benefit is not known. Previous studies addressing QOL in
patients undergoing cardiac valve surgery and the impor-
tance of age as a predictor of QOL were limited by the
absence of younger controls, cross-sectional design, small
sample size, retrospective design, and use of substandard
QOL instruments (11,14–16).
The relative lack of information on change in QOL after
major valve surgery impedes informed decision-making by
physicians and patients. Accordingly, we sought to investi-
gate whether older patients derived less health status and
QOL benefit after valve surgery than did younger patients.
To achieve this objective, we prospectively studied whether
age is associated with change in QOL at 18 months after
aortic or mitral valve surgery.
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METHODS
Study sample. We performed a longitudinal prospective
cohort study of consecutive patients undergoing isolated
valve or simultaneous valve-coronary artery bypass graft
(CABG) procedures at Yale-New Haven Hospital from
March 31, 1998, to March 30, 1999. Detailed clinical and
non-clinical information was abstracted from medical
records. During the first week after surgery, patients com-
pleted baseline questionnaires focusing on their functioning
in the month before surgery. Patients were contacted at 18
months after surgery for outcome status assessment. There
was a six-week time window allowed for follow-up ques-
tionnaire completion.
Measurement of QOL. Quality of life was measured at
baseline and at follow-up using the Medical Outcomes
Trust Short Form 36-Item Health Survey (SF-36), a survey
with demonstrated high reliability and validity (17–20). The
SF-36 consists of 36 questions, grouped into the following
eight multi-item domains, which measure functioning in
different aspects of daily life:
1) Physical functioning: limitations in lifting, climbing,
bending, kneeling, walking, or running;
2) Role physical: degree of physical health to perform
activities typical for the specific age and social responsi-
bility, such as a job, community activities, and volunteer
work;
3) Bodily pain: intensity and duration of bodily pain and
limitations in activities due to pain;
4) General health: beliefs and evaluations of overall health;
5) Vitality: feelings of energy, pep, fatigue, and tiredness;
6) Social functioning: ability to develop, maintain, and
nurture mature social relationships (including family,
friends, and spouse);
7) Role emotional: personal feelings about job performance,
work, or other activities;
8) Mental health: emotional, cognitive, and intellectual
status.
The Mental Component Summary (MCS) and the Phys-
ical Component Summary (PCS) are two meta-scores of the
SF-36. They combine eight multi-item domains and rep-
resent overall physical functioning and mental functioning
(17). These summary scales are used in this study as the
primary health-related QOL outcome variables for the
multivariable analyses. Validated U.S. population norms for
different age groups were used to gauge the significance of
the improvement in QOL after surgery (21).
Study variables. Society of Thoracic Surgery forms and
definitions were used for clinical data collection (22).
Socio-demographic variables included age, gender, and
body mass index (cut-offs: 22, 22 to 30, 30 kg/m2).
Comorbidities included renal disease, peripheral vascular
disease (PVD), chronic obstructive pulmonary disease, dia-
betes, and hypertension. Heart disease–related variables
were history of heart failure, New York Heart Association
(NYHA) functional class, ejection fraction (mainly ab-
stracted from ventriculography reports), cardiomegaly,
chronic atrial fibrillation, previous myocardial infarction,
aortic stenosis, mitral stenosis, angina type (stable or unsta-
ble), previous CABG, and previous valve procedure.
Procedure-related variables were implant type (tissue, me-
chanical, or repair), simultaneous coronary bypass, and
urgency of operation.
Statistical analysis. First, we calculated descriptive statis-
tics for the study variables. Next, after stratification of age
into three groups (64, 65 to 74, 75 years), we deter-
mined the improvement in QOL after valve surgery by
comparing QOL at baseline and at 18 months after surgery
and comparing these values with U.S. population norms.
Mean values and 95% confidence intervals were used to
demonstrate the difference. Patient scores were considered
similar to the U.S. norms if the scores were within one-
fourth of one standard deviation (SD) of the mean. This was
a conservative standard, as published guidelines to interpret
these scores suggest that even differences of one-half of one
SD are small (23). In addition, one-fourth of one SD (i.e.,
5 to 10 points) represents the difference that is considered
clinically relevant for SF-36 domains (24). For MCS and
PCS meta-scores, a clinically relevant difference is likely to
be 4 to 7 points (one-half of one SD) (25), which is, again,
larger than our conservative estimate of one-fourth of one
SD. Given our set effect size, we had over 80% power to
determine statistical significance of the change in QOL
with 95% confidence (alpha level of 0.05). Finally, we
measured the impact of age (continuous variable) on change
in QOL by multiple regression analysis of the change in two
meta-scores of the SF-36: the MCS and the PCS. We
constructed four multiple regression models (2 for aortic
and 2 for mitral subgroups). Aortic and mitral patients were
analyzed separately to determine if the association of age
with change in QOL is different after aortic or mitral
surgery. Baseline score (MCS or PCS, depending on
whether change in MCS or PCS was predicted) was the
most significant predictor of change in score from the
baseline and was included in all models. Because the
variance inflation factor did not exceed 2.5 and the tolerance
was 0.4, there was little or no evidence of colinearity
among predictors in determining the change in QOL. We
also adjusted for disease severity characteristics (cardiomeg-
aly, NYHA class), procedure type (isolated valve vs. valve
Abbreviations and Acronyms
CABG  coronary artery bypass graft surgery
MCS  Mental Component Summary
NYHA  New York Heart Association
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plus CABG), and valve implant type (tissue vs. mechanical).
In addition, we adjusted for gender and comorbid condi-
tions (hypertension, body mass index, PVD) that may
influence the change in QOL.
The generalized estimating equations method was used to
determine age-related differences in QOL changes by test-
ing the interaction between age and time and adjusting for
measurement correlation. The latter was confirmatory to
multiple regression, and only results of the multiple regres-
sion are reported here. We used the Statistical Analysis
System (SAS Institute, release 8.02, Cary, North Carolina)
for data management and analysis.
RESULTS
Cohort characteristics. Of the 285 consecutive patients
who underwent cardiac valve procedures, 220 (77.2%) par-
ticipated in the study. Reasons for non-participation in-
cluded death (n 13), neurological problems (n 10), data
entry problems (n  10), inability to administer the QOL
questionnaire before discharge (n  10), refusal (n  9),
language barriers (n  4), and other reasons (n  9). There
was no difference between the baseline participants and
non-participants with regard to age and gender. For other
characteristics, cerebrovascular accidents, PVD, and urgent
surgeries were more frequent in non-participants (Table 1).
Of 220 baseline participants, 14 patients (6.4%) died
within 18 months, leaving 206 patients available for follow-
up. All but one of the deceased patients were 65 years of
age, and half were 75 years of age. There were seven
patients (3%) who did not reply within the six-week
response period, four (2%) who refused to complete the
questionnaire, and nine (4%) who were lost to follow-up.
Thus, of the baseline participants, follow-up QOL mea-
surements at 18 months were obtained in 186 (90%) cases.
At baseline, there were 148 (67%) patients who had aortic
valve surgery and 72 (33%) patients who had mitral valve
surgery. Simultaneous valve and CABG procedures were
performed in 38% of patients, and the proportion of patients
75 years of age was 34%. Elderly patients (age 75 years)
were more likely than younger patients (age groups65 and
65 to 75 years) to have hypertension and higher NYHA
class, and they more often had valve-CABG procedures
(data not presented). They were similar to younger patients
in terms of mean ejection fraction, diabetes, and chronic
obstructive pulmonary disease.
Improvement of QOL after surgery and comparison with
normative values. There were 126 aortic and 60 mitral
patients who reported both their baseline and follow-up
QOL. Improvement in QOL after surgery was similar in
both aortic and mitral patients after stratification into three
age groups (scores were within one-fourth of one SD
compared with normative values). Thus, after age stratifi-
cation into three categories and comparisons with popula-
tion norms, the groups were combined.
All age groups showed improvement in most QOL
domains at 18 months. In the younger age group (64
years), there were statistically significant improvements in
all domains except those of general health and role emo-
tional (Fig. 1, Table 2). In the latter scales, pre-operative
norms were comparable with population norms, thus lim-
iting the possibility of recording higher absolute improve-
ments.
Among older patients (age groups 65 to 74 and 75
years), overall absolute improvements in QOL were noted
in the domains of physical functioning, role physical,
vitality, and mental health, as well as in the MCS and the
PCS meta-scores (Figs. 2 and 3, Table 2). As found in
younger patients, there was little or no absolute improve-
ment reported on the general health, role emotional, bodily
pain, and social functioning scales, where pre-operative
scores were comparable with population norms. In all age
groups, mean values for the QOL domains at 18 months
after surgery were comparable and sometimes higher than
population norms.
Effect of age on the improvement in QOL in regression
analysis. The multivariable models had good predictive
power in both aortic (R-square: 0.34 for change in MCS
and 0.48 for change in PCS) and mitral (R-square: 0.48 for
change in MCS and 0.61 for change in PCS) samples. In
the multiple regression analysis of overall mental function-
ing as measured by MCS, age was not a significant predictor
of change in score (Table 3). Similarly, after controlling for
clinically relevant factors, the association of age with the
change in overall physical functioning as measured by PCS
was small and not statistically significant in the aortic sample
(see statistical analysis) (Table 3). In contrast, age had a
statistically significant association with PCS for patients un-
dergoing mitral valve surgery. However, it was modest in
magnitude, with a 10-year increment in age resulting in a score
reduction of 1.90 (less than one-fourth of one SD).
Table 1. Comparison of Responders With Non-Responders*
Variables
Participants
(n  220)
Non-Participants
(n  65) p
Age, mean (SD) 66.5  14.4 65.1  15.1 0.52
LVEF, mean (SD) 50.8  13.2 50.0  15.8 0.74
Male gender (%) 54.5 64.6 0.15
NYHA (III–IV) class† (%) 56.4 63.1 0.53
History of MI (%) 23.6 28.1 0.46
Urgent surgery (%) 33.0 50.0 0.013
PVD (%) 13.6 26.1 0.017
CVA (%) 5.0 16.9 0.002
Diabetes (%) 15.9 23.1 0.18
Hypertension (%) 58.9 55.4 0.61
Cardiomegaly (%) 41.8 44.6 0.68
COPD (%) 20.2 29.1 0.15
Angina (%) 41.7 33.8 0.26
Aortic stenosis (%) 54.1 43.1 0.12
*Groups were also not different with regard to arrhythmia, mitral stenosis cases,
pulmonary artery pressure, family history of coronary disease, body mass index, and
reoperation. †NYHA class I–II was the reference category.
COPD  chronic obstructive pulmonary disease; CVA  cerebrovascular acci-
dent; LVEF  left ventricular ejection fraction; MI  myocardial infarction; NYHA
 New York Heart Association; PVD  peripheral vascular disease; SD  standard
deviation.
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DISCUSSION
We found that patients reported improvement in their
QOL after valve surgery in all age groups and across almost
all QOL domains. The improvements from the baseline
after 18 months were larger than one-half of one SD in
most scales of the SF-36, as well as for overall mental
functioning and physical functioning (MCS and PCS meta-
scores), supporting the clinical importance of the changes.
In addition, we found that 18 months after surgery, QOL
mean scores were comparable to U.S. population normative
scores in all age groups of patients undergoing either aortic
or mitral surgery. This is notable, given that the national
norms used for comparison with our study population were
derived from a general population of “healthy” people not
reporting any symptomatic illness (21,26).
After adjusting for clinically relevant variables, we found
that age alone was not strongly predictive of QOL improve-
ment after surgery. We did not find an association between
age and change in global mental health functioning (MCS
meta-score) for aortic or mitral patients (Table 3). The
magnitude of improvement in mental health was similar in
elderly and younger patients. Similar conclusions can be
drawn with regard to physical functioning (PCS meta-
Figure 1. Quality of life (QOL) values with 95% confidence intervals in the 64-year age group (combined mitral and aortic patients). Open boxes 
pre-operative QOL scores; open circles 18-month follow-up QOL scores; closed triangles U.S. population QOL norms for the64-year age group.
BP bodily pain; GH general health; MCSmental component summary; MHmental health; PCS physical component summary; PF physical
functioning; RE  role emotional; RP  role physical; SF  social functioning; VT  vitality.
Table 2. Preoperative, Postoperative, and Normative Mean QOL Values* in Different Age Groups
QOL
Scales
QOL Values in the
<64-Year Age Group
QOL Values in the
65–74-Year Age Group
QOL Values in the
>75-Year Age Group
Preoperative Postoperative Norms Preoperative Postoperative Norms Preoperative Postoperative Norms
PF 61  31 81  20 76 49  30 72  28 69 40  25 58  26 53
RP 43  44 80  30 74 33  41 63  41 65 17  29 42  42 45
BP 66  32 84  21 68 71  28 80  24 68 64  32 75  27 61
GH 59  11 59  9 65 57  14 59  8 63 55  12 58  8 57
VT 44  25 63  23 60 42  19 61  22 60 38  22 50  21 50
SF 71  29 84  22 81 74  25 83  23 81 71  25 75  26 74
RE 64  45 79  36 80 62  44 74  41 81 59  46 56  43 63
MH 59  11 75  19 75 59  13 78  18 81 58  11 76  16 74
MCS 45  9 50  10 51 46  9 51  11 53 46  9 49  11 50
PCS 41  10 49  6 46 39  10 45  10 43 34  8 41  9 38
*QOL values presented as means  SD.
BP  bodily pain; GH  general health; MCS  mental component summary; MH  mental health; PCS  physical component summary; PF  physical functioning;
QOL  quality of life; RE  role emotional; RP  role physical; SF  social functioning; VT  vitality.
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score). In the aortic sample, the parameter estimate for age
was small (1.00; less than one-fourth of one SD for a
10-year increment) and not statistically significant (p 
0.22) in predicting the improvement in overall physical
functioning (Table 3). In the mitral sample, the parameter
estimate for age was slightly larger (0.19) and statistically
significant (p  0.02). However, interpretation of this
estimate suggests that two otherwise identical patients
whose ages differ by 10 years can expect a PCS differential
of 1.9 points (less than one-fourth of one SD). This is
clearly a small difference, as the SD for the PCS score is 10
and differences up to one-half of one SD are considered
small in health-related QOL evaluations (23). Furthermore,
the overall results of our study suggest that older age does
not limit the QOL benefits of cardiac valve surgery.
Although other studies have compared QOL before and
after valve surgery to population norms, they were limited by
samples that excluded older or younger patients, as well as
by other aspects of study design. A study of 100 participants
by Phillips et al. (26) considered only younger patients and
obtained 67% follow-up. Later prospective studies (14,27)
that evaluated QOL after valve surgery had only six months
of follow-up, and one of these studies, based on only 32
patients, had no younger controls (14). Another cross-
sectional study included 147 elderly patients; however,
pre-operative QOL data were not available, and the study
was limited to aortic valve procedures (11). Additional
studies did not separate valve patients from isolated coro-
nary bypass patients (16,27). All previous studies reported
considerable improvement in QOL among elderly patients,
and the consistency of the results in a variety of study
designs supports the validity of the findings in the current
study.
The advantages of our study are its prospective design,
relatively large sample size, accurate control over possible
confounding, and use of a validated and widely accepted
instrument for QOL assessment. In addition, this study is
the first to evaluate long-term outcomes (18 months), as
well as the first to evaluate the impact of age on improve-
ment in QOL in aortic and mitral patients using a regres-
sion approach. Comparison of QOL scores before and after
surgery with population norms provided another estimate of
the effect of cardiac surgery on QOL improvement in
elderly and younger patients.
Study limitations. First, this study was conducted at a
single center, perhaps limiting its generalizability. However,
we compared our sample with the Society of Thoracic
Surgeons summary data from 1991 to 1995 (28) and found
the patients to be similar. Second, because we were unable
to interview patients before surgery, baseline QOL data
were obtained during the first week after surgery. However,
patients were asked to report their QOL in the month
before surgery. Third, we attempted to enroll every patient
but were not able to do so. In addition, we compared
participants with non-participants and found that the two
groups were not different with regard to major risk factors.
Fourth, we did not test for cognitive decline that can
potentially be associated with QOL. Finally, our findings
Figure 2. Quality of life (QOL) values with 95% confidence intervals in the 65- to 74-year age group (combined mitral and aortic patients). Open boxes
 pre-operative QOL scores; open circles 18-month follow-up QOL scores; closed triangles U.S. population norms for the 65- to 74-year age group.
BP bodily pain; GH general health; MCSmental component summary; MHmental health; PCS physical component summary; PF physical
functioning; RE  role emotional; RP  role physical; SF  social functioning; VT  vitality.
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are relevant to patients being referred for valve surgery, and
their relevance to patients with mitral or aortic disease who
did not undergo surgery is unknown. It is possible that
concerns about recovery lead some physicians not to recom-
mend surgery to some older patients who might have a
different recovery experience. Nevertheless, we believe that
these limitations had a minor impact on our finding that age
does not limit QOL benefits that can be attained after
surgery.
Conclusions. Patients reported improved QOL at 18
months after aortic and mitral surgery that was comparable
to population norms for their age. Among patients currently
referred for cardiac valve surgery, age does not appear to
independently influence or limit the improvement in QOL.
Elderly patients should be educated about the expected
health status benefits associated with valve surgery. Further-
more, these findings should help surgeons and elderly
patients to make informed decisions regarding the suitabil-
ity of the valve surgery.
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